Itch

It's a sunny afternoon, and you're enjoying the moment on a park bench. A warm breeze is blowing, everything is peaceful… everything is perfect. Then, you feel a tiny tickle on your arm. Before you notice and wave your hand away, everything is over: a tiny mosquito flies away, leaving behind a small, red dot. At that very moment, the peaceful tranquility of your body ends, and an invisible adventure begins. This tiny bite is the birth of a decisive message, which we will call the "Itch Signal," the protagonist of our story.

Alarm Bells Are Ringing! (The Bite and the First Reaction)

That tiny mosquito, to comfortably suck your blood, leaves not only its stinger but also a special substance (anticoagulant) under your skin that prevents blood clotting. For your body's intelligent immune system, this foreign molecule is a red-flagged invader. Within seconds, alarm bells start ringing in the area, and the body releases chemical messengers called histamine . You can think of histamine as a distress signal calling for emergency support. This chemical call causes blood vessels in the bite area to dilate. Its purpose is simple: to clear the way for reinforcements of immune cells to reach the area more quickly to fight the threat. The swelling and redness you feel at that moment are actually the first visible signs of a meticulously managed defense operation by your body. But this chemical alarm doesn't just initiate a defense; it also lays the groundwork for the birth of a very specific message.

So what kind of message does this chemical alarm send to the brain? "Help!"? "Danger!"? No, the body has a much more specific messenger. The released histamine activates special nerve endings in the skin that are sensitive to itching. And that's where the real hero of our story comes in: Natriuretic Polypeptide B (NPPB) .

A groundbreaking study published in Science in 2013, conducted on mice, revealed the central role of this molecule. In this experiment, mice genetically incapable of producing NPPB showed no itching response when exposed to chemicals known to cause itching. While these mice continued to feel other sensations such as pain, touch, and heat, they specifically lost the sensation of itching. This result strongly suggests that NPPB is a specialized neurotransmitter that carries the itching signal from the skin to the spinal cord and then to the brain.

However, treating chronic itching by blocking NPPB is not a simple solution. This is because this molecule has a dual role in the body: in addition to transmitting the itching signal, it is secreted by the heart, regulating sodium excretion in the kidneys and thus controlling blood pressure. Therefore, the potential side effects of treatments targeting NPPB should be carefully evaluated.

Elucidating the NPPB-mediated signaling pathway allows us to understand the initiation of the itch signal; the scratching action itself, the motor response to this signal, is a complex feedback mechanism that triggers a distinct neurochemical cascade in the central nervous system.

The NPPB is our fast and elite "messenger." It has one clear and simple task: to deliver the message, "There's a problem here, and it's itching !" to the body's command center, the brain.

The long-standing notion that itching is a subtype of pain stems from the fact that both sensations share common afferent nerve pathways, such as C-fibers, to transmit signals from the periphery to the central nervous system. However, recent findings have demonstrated the existence of a specialized subset of neurons carrying itching-specific signals along these common pathways. Specifically, a group of receptors and neurons, called prurireceptors , located within the pain-related nerve fibers in the skin, have been shown to respond specifically to itching stimuli. This finding has elevated itching from a mild ache to an independent sensation with its own starting point and signaling mechanism. In other words, itching is not a subtype of pain, but a distinct, unique sensation. To use an analogy: while pain and itching share the same highway, pain travels in an ordinary vehicle, while the itching signal uses a specialized "sports car," like the NPPB, designed specifically for this purpose. This ensures the brain never confuses the incoming message.

Our messenger, NPPB, sets off as soon as it receives its mission order. Starting from the nerve ending in the skin, it travels at incredible speed along the nerve fibers that crisscross the body like a network. These nerve fibers are like a "super highway to the brain," carrying messages from all over the body to the center. The signal's first major stop on this highway is the spinal cord, a transmission hub where all neural traffic from the body is collected and organized. Passing through here, NPPB enters the final leg of its journey and reaches its ultimate destination: the brain. As soon as the brain receives this special "NPPB" signed message, it instantly interprets the situation: ITCH! And in seconds, it issues a counter-command: "Scratch there!" This clear command from the brain will open a brand new and much more complex chapter in our story.

The basic mechanism behind the temporary relief provided by scratching is based on the suppression of itching signals by pain signals. Scratching the skin with fingernails actually creates a low-level pain signal by causing slight damage to the skin. When these pain signals reach the spinal cord, they activate inhibitory interneurons at the spinal level, modulating or suppressing the original itching signals. This phenomenon can be thought of as a reflection of the 'gate control theory,' where the pain signal temporarily closes the 'gate' through which the itching signal reaches the brain. Because the pain signal is much more dominant and "noisy," it suppresses the weaker itching signal (NPPB), making it virtually "inaudible." The brain now perceives the mild pain caused by scratching, not the itching itself. That's the secret to that momentary, sweet relief.

So why does itching feel so satisfying, and why is this relief always so short-lived? That's where the most interesting trap of the story begins.

The Feel-Good Trap: The Serotonin Cycle

When the brain receives the mild pain signal from scratching, it makes a move to relieve the pain and reward you: it releases serotonin . Often known as the "happiness hormone," serotonin gives you a feeling of pleasure and satisfaction while reducing pain. This is why scratching is so enjoyable. However, this well-intentioned intervention has an unexpected consequence. After completing its task of relieving pain, serotonin travels back from the brain to the spinal cord, attempting to calm the nerves in that area. But in the process, it also stimulates the specific nerves that initiate the itching signal! We can liken this to accidentally pouring gasoline on a small fire while trying to put it out with water. As a result, that sweet relief disappears shortly after you stop scratching, and the itching returns even stronger than before. This is called the "Scratch-Scratch Cycle."

Many people experience the sensation of the itch "moving" to another nearby area after scratching a spot. While the underlying mechanisms of this phenomenon are not fully understood, two main theories have been proposed:

• Signal Intensity and Local Ambiguity: The number of itching receptors in our skin far exceeds the number of afferent nerve fibers that carry these signals to the spinal cord. Therefore, signals from multiple receptors can converge on a single nerve fiber. When the signal reaches the brain, the central nervous system may not be able to precisely determine the origin of the signal and only perceives a general area. This "prediction" error can lead to the itching feeling as if it is shifting location.

• Serotonin Effect: Serotonin, released after scratching, is known to stimulate itch neurons in the spinal cord. This neurochemical release can also activate nerves near the original itching point, causing new and intensified itching to be perceived as coming from a nearby area.

It is likely that these two mechanisms, signal ambiguity and neurochemical propagation, act simultaneously to create the perception of "moving itch." This complex physiology of the scratching action provides an important foundation for understanding the evolutionary and clinical dimensions of the issue.

At first glance, itching might seem like an annoying design flaw, but it's actually a highly beneficial evolutionary defense mechanism that keeps us alive. Our scratching reflex is designed to physically remove potential threats from our skin – a harmful insect, a parasite, or a poisonous plant leaf. This simple yet effective alarm system protects us from countless threats in the outside world. In short, the adventure that begins with a mosquito bite turns into a complex cycle: a histamine alarm, the specific message of NPPB, a highway journey to the brain, the pain signal created by scratching, and the sweet trap of serotonin.

And perhaps the strangest part of this story is that itching can be contagious. Just like yawning, seeing someone else itch or even just talking about itching can make you itch. There's an evolutionary logic to this: If someone in your group is itching because of parasites, you might also be at risk. So your body encourages you to itch as a precaution.

When itching ceases to be a basic protective mechanism and becomes chronic due to disruptions in nerve pathways or other underlying diseases, it can transform into a symptom that severely reduces quality of life. Two specific pathological conditions exemplify this phenomenon:

• Delusional Parasitosis: This is a psychiatric disorder in which patients have an irrefutable delusion that their bodies are infested with invisible insects, mites, or other parasites. This false belief causes patients to scratch incessantly and uncontrollably to the point of damaging their skin.

• Phantom Itching: This condition often occurs after limb amputation. Severe damage to the nervous system causes the brain to misinterpret normal nerve signals. As a result, patients may experience intense itching in the limb that is no longer physically present. Mirror reflection therapy, used in treatment, involves the patient watching their reflection in a mirror while scratching their healthy limb. This visual feedback can trick the brain into believing the phantom itch is being relieved, thus alleviating symptoms.

The fact that itching can be both a basic protective mechanism and a serious clinical problem demonstrates how complex and multifaceted this sensation is.

The next time you experience an unbearable itch, stop and think for a moment. It's not just a discomfort; it's elegant proof of the complex, intelligent, and even contradictory systems your body employs to protect you.

Resources and Suggested Readings:

Mishra, SK, Hoon, MA (2013). The cells and circuitry for itch responses in mice . Science, 340 (6135), 968–971

Thurmond, R.L., Gelfand, E.W., Dunford, P.J. (2008). The role of histamine H1 and H4 receptors in allergic inflammation . Journal of Allergy and Clinical Immunology, 121 (1), 73–83.

Bautista, DM, Wilson, SR, Hoon, MA (2014). Why we scratch an itch: The molecules, cells and circuits of itch . Nature Neuroscience, 17 (2), 175–182.

Sun, Y.G., Chen, Z.F. (2007). A gastrin-releasing peptide receptor mediates the itch sensation in the spinal cord . Nature, 448 (7154), 700–703.

Melzack, R., Wall, P. D. (1965). Pain mechanisms: A new theory . Science, 150 (3699), 971–979.

Zhao, ZQ, Liu, XY, Jeffry, J., et al. (2014). Chronic itch development in sensory neurons requires BRAF signaling pathways . Cell Reports, 6 (3), 490–499.

Papoiu, ADP, Coghill, RC, Kraft, RA, Wang, H., Yosipovitch, G. (2012). A tale of two itches: Common features and distinct differences in brain activation . Journal of Investigative Dermatology, 132 (3), 663–670.

Yosipovitch, G., Bernhard, J. D. (2013). Clinical practice: Chronic pruritus . New England Journal of Medicine, 368 (17), 1625–1634.

Holle, H., Warne, K., Seth, AK, Critchley, HD, Ward, J. (2012). Neural basis of contagious itch and why some people are more susceptible . Proceedings of the National Academy of Sciences, 109 (48), 19816–19821.

Oaklander, A.L., Fields, H.L. (2009). Is phantom limb pain a neuropathic pain? Pain, 141 (1–2), 1–3.

Hylwa, SA, Bury, JE, Davis, MDP (2011). Delusional infestation: State of the art . Acta Dermato-Venereologica, 91 (5), 552–558.